Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$138.1M
+58.5% from 2023
Prescriptions
9,510
$14,521.94 per claim
Patients
1,872
1,682 prescribers
Total spending, 2024
$138.1M
$73,773.33 per patient
Medicare prescription drug plans paid $138.1M for Braftovi in 2024, for 9,510 prescriptions and refills to 1,872 patients (up 58.5% from 2023). The average cost per claim was $14,521.94.
California had the highest Medicare cost for Braftovi in 2024: $15.1M for 1,067 claims, followed by Florida ($11.3M).
Rodabe Amaria, medical oncology in Houston, TX, had the highest Medicare cost for Braftovi in 2024: 69 claims costing $1.0M.
Braftovi is made by Pfizer Inc. (PFE), listed in the Medicare spending data as Array/Pfizer.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Rodabe Amaria Houston, TX | Medical Oncology | 69 | Under 11 | $1.0M |
| Aimee D Kohn Portland, OR | Medical Oncology | 55 | Under 11 | $846K |
| Isabella C Glitza |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 1,291 | 7,725 | 1,527 | $100.5M |
| 2023 | 1,230 | 6,162 | 1,326 | $87.1M |
| 2024 | 1,682 | 9,510 | 1,872 | $138.1M |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Internal Medicine |
| 51 |
| Under 11 |
| $796K |
| Yuanbin Chen Orlando, FL | Hematology-Oncology | 43 | Under 11 | $790K |
| Melinda L Yushak New Haven, CT | Hematology-Oncology | 50 | Under 11 | $733K |
| Jose Lutzky Miami, FL | Hematology-Oncology | 53 | Under 11 | $710K |
| Robert C Lufkin Portland, OR | Medical Oncology | 48 | Under 11 | $700K |
| Douglas B Johnson Nashville, TN | Medical Oncology | 55 | Under 11 | $695K |
| Asim Amin Charlotte, NC | Medical Oncology | 43 | Under 11 | $667K |
| Parisa Momtaz West Harrison, NY | Hematology-Oncology | 44 | 11 | $664K |
| Hussein A Tawbi Houston, TX | Internal Medicine | 43 | Under 11 | $645K |
| George Ansstas Saint Louis, MO | Medical Oncology | 39 | Under 11 | $631K |
| Melissa Wilson Easton, PA | Medical Oncology | 41 | Under 11 | $612K |
| Riley M Fadden Boston, MA | Nurse Practitioner | 40 | Under 11 | $610K |
| Jason Chesney Louisville, KY | Hematology-Oncology | 37 | Under 11 | $598K |
| Suzanne McGettigan Philadelphia, PA | Nurse Practitioner | 41 | Under 11 | $589K |
| Ankit Mangla Cleveland, OH | Hematology-Oncology | 32 | Under 11 | $544K |
| Michele Nanni Buffalo, NY | Physician Assistant | 35 | Under 11 | $539K |
| Bartosz Chmielowski Los Angeles, CA | Hematology-Oncology | 36 | Under 11 | $539K |
| Mohammed M Milhem Iowa City, IA | Hematology-Oncology | 39 | Under 11 | $526K |
| Adi Diab Houston, TX | Medical Oncology | 28 | Under 11 | $485K |
| Kristin L Kreider Philadelphia, PA | Physician Assistant | 37 | Under 11 | $473K |
| William Sharfman Lutherville, MD | Medical Oncology | 31 | Under 11 | $464K |
| Matthew S Block Rochester, MN | Medical Oncology | 38 | Under 11 | $459K |
| Michael Wong Buffalo, NY | Medical Oncology | 30 | Under 11 | $457K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Array/Pfizer PFE | 9,510 | $138.1M |